Nigeria SmartBag Blockchain Pioneer and Provider, Temie Wins Jack Ma's $250,000 Funding for African Startups.

Share this:

At the grand-finale of the Africa Netpreneur Prize Initiative (ANPI) held in Accra, Ghana. The smartBag blockchain pioneer Temie Giwa-Tubosun has taken home the top prize.

Africa Netpreneur Prize Initiative (ANPI), pioneered by Chinese investor Jack Ma has made available $1 million for the 10 finalist that will emerge from the competition. Temie Giwa-Tubosun takes the first price reward home worth $250,000 cash prize

About 10,000 entrepreneurs from 50 African countries applied for the competition. Only 10 applicants was selected for the “Africa’s Business Heroes,” finale event, held Saturday in Ghana.

The lucky 10 finalist presented it’s business to the four judges including Jack Ma, Zimbabwean businessman Strive Masiyiwa, Joe Tsai and Vice Chairman Alibaba Group Ibukun Awosika.

SmartBag blockchain pioneer and Lifebank Founder and CEO Temie came first followed by Egyptian Omar Sakr, founder and CEO, Nawah-Scientific. The third winner was Christelle Kwizera, founder, Water Access Rwanda.

Temie got $250,000 grant while Omar got $50,000 grant and Kwizera was awarded $100,000. The remaining finalists were awarded $65,000 grant each for their various businesses.

About SmartBag Blockchain

SmartBag Blockchain is an Innovative Smart Blood Transit System. SmartBag is a blockchain powered product that aids in checking the safety record of blood by patients and healthcare providers. It was created by LifeBank, a blood transit company and provider.

How SmartBag Blockchain Works:

Information about each SmartBag is available and easily accessible through a web application.

For hospitals, healthcare specialists, researchers and providers with no access to smartphones, computers or the internet, this records will be accessible through USSD short codes.

This technology can also be used register and monitor the distribution chain of controlled drugs such as codeine and tramadol. It will help to fight against drug counterfeiting in developing countries.